Compositions and methods for immunooncology
US-2024417722-A1 · Dec 19, 2024 · US
US9775919B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9775919-B2 |
| Application number | US-201615202716-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 6, 2016 |
| Priority date | Jan 17, 2012 |
| Publication date | Oct 3, 2017 |
| Grant date | Oct 3, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention discloses biocompatible, stable curcumin or its derivatives coated ultra-small super paramagnetic iron oxide nanoparticles (USPION) for biomedical applications. Disclosed herein is also a simple one-pot process for the synthesis of biocompatible, stable curcumin or its derivatives coated ultra-small superparamagnetic iron oxide nanoparticles in absence of a linker or binder. The curcumin or its derivatives coated ultra-small super paramagnetic iron oxide nanoparticles of the present invention retains the medicinal, radical scavenging and fluorescence properties of curcumin.
Opening claim text (preview).
The invention claimed is: 1. A one-pot process for the synthesis of curcumin coated magnetite nanoparticles, which are biocompatible, stable curcumin coated ultra-small super paramagnetic iron oxide nanoparticles devoid of a linker or binder, the process comprising: (a) dissolving aqueous mixture of FeCl 3 .6H 2 O and FeCl 2 .4H 2 O in the molar ratio ranging between 1.5:1 to 2:1 in a base under inert atmosphere and stirring until complete formation and growth of magnetite nanoparticles; (b) adding dilute mineral acid to the solution as obtained in step (a) until the solution has a pH of about 9; (c) adding drop wise curcumin solution dissolved in a base to the solution of step (b) under inert atmosphere, maintaining the pH at about 9 followed by stirring the dispersion at a temperature in the range of 50-100° C. followed by cooling; and (d) dialysing the dispersion of step (c) against water to remove excess curcumin and drying in a vacuum to obtain the product. 2. The process according to claim 1 , wherein the base used is an alkali hydroxide. 3. The process according to claim 2 , wherein the alkali hydroxide is ammonium hydroxide. 4. The process according to claim 1 , wherein the mineral acid used is nitric acid. 5. The process according to claim 1 , wherein the curcumin coated magnetite nanoparticles have a particle size of about 3 nm.
involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis · CPC title
having a (super)(para)magnetic core coated or functionalised with a small organic molecule (oligomeric, polymeric, dendrimeric A61K49/1851) · CPC title
Processes · CPC title
Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors · CPC title
Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.